{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:18:07Z","timestamp":1765354687547},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s43032-019-00080-x","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:03:47Z","timestamp":1581707027000},"page":"743-750","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial"],"prefix":"10.1007","volume":"27","author":[{"given":"Nesreen AbdelFattah AbdAllah","family":"Shehata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada Abdel Fattah Abdel","family":"Moety","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamada Ashry Abd","family":"El Wahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf Samir","family":"Fahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha Ali","family":"Katta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaber Khalaf","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"80_CR1","doi-asserted-by":"crossref","unstructured":"Nuckols CC. American Psychiatric Association: diagnostic and statistical manual of mental health disorders. 5th edn, vol. 2. Washington, DC: American Psychiatric Association; 2013. pp. 45\u20136.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"80_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/S0033291701004925","volume":"32","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32:119\u2013321.","journal-title":"Psychol Med"},{"key":"80_CR3","volume-title":"Green Top Guideline No 48","author":"Royal College of Obstetricians and Gynecologists","year":"2007","unstructured":"Royal College of Obstetricians and Gynecologists. Green Top Guideline No 48. London: RCOG press; 2007."},{"issue":"3","key":"80_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","volume":"106","author":"KA Yonkers","year":"2005","unstructured":"Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005;106(3):492\u2013501.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"80_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/15246090152543148","volume":"10","author":"EW Freeman","year":"2001","unstructured":"Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med. 2001;10(6):561\u20139.","journal-title":"J Womens Health Gend Based Med"},{"key":"80_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OAJC.S97013","volume":"7","author":"I Lete","year":"2016","unstructured":"Lete I, Lapuente O. Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review. Open Access J Contracept. 2016;7:117\u201325.","journal-title":"Open Access J Contracept"},{"key":"80_CR7","volume":"2","author":"LM Lopez","year":"2012","unstructured":"Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev. 2012;2:CD006586.","journal-title":"Cochrane Database Syst Rev"},{"key":"80_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.maturitas.2012.03.007","volume":"72","author":"LJ Baker","year":"2012","unstructured":"Baker LJ, O\u2019Brien PMS. Premenstrual syndrome (PMS): A peri-menopausal perspective. Maturitas. 2012;72:121\u20135.","journal-title":"Maturitas"},{"key":"80_CR9","volume":"6","author":"J Marjoribanks","year":"2013","unstructured":"Marjoribanks J, Brown J, O'brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;6:CD001396.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"80_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/JCP.0b013e31829c7697","volume":"33","author":"KA Yonkers","year":"2013","unstructured":"Yonkers KA, Pearlstein TB, Gotman N. A pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome. J Clin Psychopharmacol. 2013;33(5):614\u201320.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"80_CR11","first-page":"435","volume":"100","author":"LS Cohen","year":"2002","unstructured":"Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol. 2002;100(3):435\u201344.","journal-title":"Obstet Gynecol"},{"key":"80_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/01.jcp.0000138767.53976.10","volume":"24","author":"LS Cohen","year":"2004","unstructured":"Cohen LS, Soares CN, Lyster A, Cassano P, Brandes M, Leblanc GA. Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol. 2004;24:540\u20133.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"80_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","volume":"9","author":"J Endicott","year":"2006","unstructured":"Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9(1):41\u20139.","journal-title":"Arch Womens Ment Health"},{"key":"80_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-clinpsy-050212-185510","volume":"9","author":"TJ Trull","year":"2013","unstructured":"Trull TJ, Ebner-priemer U. Ambulatory assessment. Annu Rev Clin Psychol. 2013;9:151\u201376.","journal-title":"Annu Rev Clin Psychol"},{"key":"80_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","volume":"14","author":"PM O\u2019Brien","year":"2011","unstructured":"O\u2019Brien PM, B\u00e4ckstr\u00f6m T, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14:13\u201321.","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"80_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/ejc.8.1.37.51","volume":"8","author":"D Apter","year":"2003","unstructured":"Apter D, Borsos A, Baumg\u00e4rtner W, Melis GB, Vexiau-Robert D, Colligs-Hakert A, et al. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod. 2003;8(1):37\u201351.","journal-title":"Eur J Contracept Reprod"},{"issue":"1","key":"80_CR17","first-page":"14","volume":"47","author":"C Brown","year":"2002","unstructured":"Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. J Reprod Med. 2002;47(1):14\u201322.","journal-title":"J Reprod Med"},{"key":"80_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0960-0760(90)90490-C","volume":"37","author":"E-E Baulieu","year":"1990","unstructured":"Baulieu E-E, Robel P. Neuroactive steroids, a new brain function? J Steroid Biochem Mol Biol. 1990;37:395\u2013403.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"80_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","volume":"186","author":"DS Reddy","year":"2010","unstructured":"Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113\u201337.","journal-title":"Prog Brain Res"},{"key":"80_CR20","doi-asserted-by":"publisher","first-page":"487143","DOI":"10.1155\/2013\/487143","volume":"2013","author":"J Wichianpitaya","year":"2013","unstructured":"Wichianpitaya J, Taneepanichskul S. A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms. Obstet Gynecol Int. 2013;2013:487143.","journal-title":"Obstet Gynecol Int"},{"issue":"3","key":"80_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","volume":"36","author":"CA Graham","year":"1992","unstructured":"Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res. 1992;36(3):257\u201366.","journal-title":"J Psychosom Res"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43032-019-00080-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00080-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T01:09:52Z","timestamp":1609808992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43032-019-00080-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1007\/s43032-019-00080-x","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"16 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict(s) of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}